Table 3.
Rebleeding rate on follow-up procedures for significant capsule finding
| Finding | Endoscopic | Surgical | Radiographic | Drug | Without intervention | Total |
| Overall | 5/12 (41.7%) | 0/9 (0%) | 0/1 (0%) | 1/8 (12.5%) | 6/15 (40.0%) | 12/45 (26.7%) |
| Ulcer | 0/4 (0%) | 0 | 0 | 1/5 (20.0%) | 4/7 (57.1%) | 5/16 (31.2%) |
| Angiodysplasia | 2/4 (50.0%) | 0/2 (0%) | 0 | 0/1 (0%) | 2/6 (33.3%) | 4/13 (30.8%) |
| Tumor | 1/1 (100%) | 0/7 (0%) | 0 | 0 | 0 | 1/8 (12.5%) |
| Bleeding without identifiable lesion | 2/3 (66.7%) | 0 | 0/1 (0%) | 0/1 (0%) | 0/2 (0%) | 2/7 (28.6%) |
| Crohn's disease | 0 | 0 | 0 | 0/1 (0%) | 0 | 0/1 (0%) |